Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10227)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2022 (publication date) through Feb 11, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Said I, Ahad H, Said A. Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics. World J Gastrointest Oncol 2022; 14(5): 947-958 [PMID: 35646285 DOI: 10.4251/wjgo.v14.i5.947] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Said I, Ahad H, Said A. Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics. World J Gastrointest Oncol 2022; 14(5): 947-958 [PMID: 35646285 DOI: 10.4251/wjgo.v14.i5.947] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v14/i5/947.htm |
| Number | Citing Articles |
| 1 |
Maryam K. Ibrahim, Tracey G. Simon, Mary E. Rinella. Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2023; 27(2): 251 doi: 10.1016/j.cld.2023.01.004
|
| 2 |
Mohamed Salaheldin, Heba Aly, Louis Lau, Shimaa Afify, Mohamed El-Kassas. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: The Next Threat after Viral Hepatitis. Diagnostics 2023; 13(16): 2631 doi: 10.3390/diagnostics13162631
|
| 3 |
Connor Campbell, Mrunmayee R. Kandalgaonkar, Rachel M. Golonka, Beng San Yeoh, Matam Vijay-Kumar, Piu Saha. Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy. Biomedicines 2023; 11(2): 294 doi: 10.3390/biomedicines11020294
|
| 4 |
Jie-ping Wang, Meng-yu Zhang, Ming Luo, Shu Qin, Xian-ming Xia. Effect of FXR agonist GW4064 in the treatment of hilar cholangiocarcinoma in rats. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23539-5
|
| 5 |
Lei Chen, Meijun Liu, Xiaoli Chen, Aiping Lyu, Kenneth Cheung, Yongai Xiong. Interactions between traditional chinese medicine and gut microbiota in chronic diseases. Pharmacological Research - Modern Chinese Medicine 2025; 16: 100659 doi: 10.1016/j.prmcm.2025.100659
|
| 6 |
Rui Xiao, Yang Cao, Linlin Wang, Peijun Tian, Qixiao Zhai, Jianxin Zhao, Gang Wang, Yu Zhu. The role of probiotics in the treatment of non-alcoholic fatty liver disease (NAFLD): New insights based on meta-analysis and subgroup analysis. Food Bioscience 2024; 62: 105454 doi: 10.1016/j.fbio.2024.105454
|
| 7 |
Xiumei Guo, Ying Zhao, Yanbing Pan, Jinrun Huang, Zhensan Wang, Pengkun Li, Weijuan Yuan, Yilin He, Jingshuo Qiu, Jinkang Dong, Zhihui Yan, Xinyue Zhang, Lintao Wang, Chengjie Guo, Yang An, Shuangyu Lv. Deciphering influence and therapeutic significance of gut microbiota and its metabolites on metabolic diseases and inflammatory bowel disease. Clinical Nutrition ESPEN 2025; 70: 434 doi: 10.1016/j.clnesp.2025.10.021
|
| 8 |
Renuka Sri Sai Peddireddi, Sai Kiran Kuchana, Rohith Kode, Saketh Khammammettu, Aishwarya Koppanatham, Supriya Mattigiri, Harshavardhan Gobburi, Suresh K. Alahari. Role of Gut Microbiome in Oncogenesis and Oncotherapies. Cancers 2025; 18(1): 99 doi: 10.3390/cancers18010099
|
| 9 |
Stergios A. Polyzos, Lampros Chrysavgis, Ilias D. Vachliotis, Evangelos Chartampilas, Evangelos Cholongitas. Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy. Seminars in Cancer Biology 2023; 93: 20 doi: 10.1016/j.semcancer.2023.04.010
|
| 10 |
阳阳 张. Discussion on the Influence of Intestinal Flora Disturbance on Diabetic Nephropathy and the Treatment of Traditional Chinese Medicine Based on the Theory of “Entero-Renal Axis”. Traditional Chinese Medicine 2024; 13(09): 2435 doi: 10.12677/tcm.2024.139361
|
| 11 |
Qinge Ma, Kejia Liu, Chenyu Chang, Lei Wang, Zhangyang Shen, Jiaxin Li, Mozili Adu, Qingyuan Lin, Huilian Huang, Xutao Wu, Rongrui Wei. Metabolic dysfunction‑associated steatotic liver disease: Pathogenesis, model and treatment (Review). International Journal of Molecular Medicine 2025; 56(6): 1 doi: 10.3892/ijmm.2025.5668
|
| 12 |
Gursimran Singh, Shazia Ansari, Satyam Yadav, Khadga Raj Aran. Gut microbiota's role in NAFLD- and HBV/HCV-related hepatocellular carcinoma: Mechanisms and therapeutic implications. Microbial Pathogenesis 2026; 211: 108273 doi: 10.1016/j.micpath.2025.108273
|
| 13 |
Ming Ren Toh, Evelyn Yi Ting Wong, Sunny Hei Wong, Alvin Wei Tian Ng, Lit-Hsin Loo, Pierce Kah-Hoe Chow, Joanne Ngeow. Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology 2023; 164(5): 766 doi: 10.1053/j.gastro.2023.01.033
|
| 14 |
Tamiris Ingrid Petito‐da‐Silva, Felipe Missiba Villardi, Aline Penna‐de‐Carvalho, Carlos Alberto Mandarim‐de‐Lacerda, Vanessa Souza‐Mello, Sandra Barbosa‐da‐Silva. An Intestinal FXR Agonist Mitigates Dysbiosis, Intestinal Tight Junctions, and Inflammation in High‐Fat Diet‐Fed Mice. Molecular Nutrition & Food Research 2024; 68(4) doi: 10.1002/mnfr.202300148
|
| 15 |
Bin Li, Xiaochen Chi, Ying Huang, Weitong Wang, Zhuo Liu. Bifidobacterium longum-Derived Extracellular Vesicles Prevent Hepatocellular Carcinoma by Modulating the TGF-β1/Smad Signaling in Mice. Frontiers in Bioscience-Landmark 2024; 29(7) doi: 10.31083/j.fbl2907241
|
| 16 |
Maria Pallozzi, Valeria De Gaetano, Natalia Di Tommaso, Lucia Cerrito, Francesco Santopaolo, Leonardo Stella, Antonio Gasbarrini, Francesca Romana Ponziani. Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers. Nutrients 2024; 16(14): 2372 doi: 10.3390/nu16142372
|
| 17 |
Fahad Alfhaid. A Review of the Gut Microbiome and Its Role in Non-alcoholic Fatty Liver Disease. Advances in Human Biology 2025; doi: 10.4103/aihb.aihb_19_25
|
| 18 |
Lisi Liu, Xun Duan, Baozhao Ju. Recent advances in non-alcoholic steatohepatitis-associated hepatocellular carcinoma: immune cells, metabolic dysregulation, and therapeutic strategies. Frontiers in Oncology 2026; 15 doi: 10.3389/fonc.2025.1744299
|
| 19 |
Ernesto Saenz, Nathally Espinosa Montagut, Baohong Wang, Christoph Stein-Thöringer, Kaicen Wang, Honglei Weng, Matthias Ebert, Kai Markus Schneider, Lanjuan Li, Andreas Teufel. Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges. Engineering 2024; 40: 51 doi: 10.1016/j.eng.2024.03.019
|
| 20 |
Yu Geng, Lanqing Liu, Yongping Sun, Lijuan Guo, Yuanjing Wu, Zhen Jia. Metabolic dysregulation in MASLD-associated HCC: diagnostic biomarkers and therapeutic opportunities. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1705723
|
| 21 |
Rong Feng, Liang Chen, Ming Yang. Aluminum-induced oxidative stress promotes changes in the structure of the gut microbiota and liver deficiency. Heliyon 2024; 10(16): e36165 doi: 10.1016/j.heliyon.2024.e36165
|
| 22 |
Himanshi Goyal, Kaneez Fatima, Jyotdeep Kaur. Understanding crosstalk between the gut and liver microbiome: pathogenesis to therapeutic approaches in liver cancer. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03840-9
|
| 23 |
Sara Tharwat Abdullah, Snur Rasool Abdullah, Bashdar Mahmud Hussen, Yousif Mohammed Younis, Mohammed Fatih Rasul, Mohammad Taheri. Role of circular RNAs and gut microbiome in gastrointestinal cancers and therapeutic targets. Non-coding RNA Research 2024; 9(1): 236 doi: 10.1016/j.ncrna.2023.12.002
|